Literature DB >> 25255676

Factor analysis of the modified Sexual Adjustment Questionnaire-Male.

Margaret C Wilmoth, Alexandra L Hanlon, Lit Soo Ng, Debra W Bruner.   

Abstract

BACKGROUND AND
PURPOSE: The Sexual Adjustment Questionnaire (SAQ) is used in National Cancer Institute-sponsored clinical trials as an outcome measure for sexual functioning. The tool was revised to meet the needs for a clinically useful, theory-based outcome measure for use in both research and clinical settings. This report describes the modifications and validity testing of the modified Sexual Adjustment Questionnaire-Male (mSAQ-Male).
METHODS: This secondary analysis of data from a large Radiation Therapy Oncology Group trial employed principal axis factor analytic techniques in estimating validity of the revised tool. The sample size was 686; most subjects were White, older than the age 60 years, and with a high school education and a Karnofsky performance scale (KPS) score of greater than 90.
RESULTS: A 16-item, 3-factor solution resulted from the factor analysis. The mSAQ-Male was also found to be sensitive to changes in physical sexual functioning as measured by the KPS.
CONCLUSION: The mSAQ-Male is a valid self-report measure of sexuality that can be used clinically to detect changes in male sexual functioning.

Entities:  

Mesh:

Year:  2014        PMID: 25255676      PMCID: PMC4663983          DOI: 10.1891/1061-3749.22.2.241

Source DB:  PubMed          Journal:  J Nurs Meas        ISSN: 1061-3749


  13 in total

1.  A RATIONALE AND TEST FOR THE NUMBER OF FACTORS IN FACTOR ANALYSIS.

Authors:  J L HORN
Journal:  Psychometrika       Date:  1965-06       Impact factor: 2.500

2.  Recovery of Weak Common Factors by Maximum Likelihood and Ordinary Least Squares Estimation.

Authors:  Nancy E Briggs; Robert C MacCallum
Journal:  Multivariate Behav Res       Date:  2003-01-01       Impact factor: 5.923

3.  Model modifications in covariance structure analysis: the problem of capitalization on chance.

Authors:  R C MacCallum; M Roznowski; L B Necowitz
Journal:  Psychol Bull       Date:  1992-05       Impact factor: 17.737

4.  Research instruments for the diagnosis and treatment of patients with erectile dysfunction.

Authors:  Raymond C Rosen; Stanley E Althof; François Giuliano
Journal:  Urology       Date:  2006-09       Impact factor: 2.649

5.  Radiotherapy and short-term androgen deprivation for localized prostate cancer.

Authors:  Christopher U Jones; Daniel Hunt; David G McGowan; Mahul B Amin; Michael P Chetner; Deborah W Bruner; Mark H Leibenhaut; Siraj M Husain; Marvin Rotman; Luis Souhami; Howard M Sandler; William U Shipley
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

Review 6.  Sexual functioning in older adults.

Authors:  John DeLamater; Amelia Karraker
Journal:  Curr Psychiatry Rep       Date:  2009-02       Impact factor: 5.285

7.  Potent men undergoing radical prostatectomy: a prospective study measuring sexual health outcomes and the impact of erectile dysfunction treatments.

Authors:  Bruce L Dalkin; Bea Anne Christopher
Journal:  Urol Oncol       Date:  2007-11-07       Impact factor: 3.498

8.  A comparison of patient and partner responses to a brief sexual function questionnaire.

Authors:  S D Mathias; M P O'Leary; J M Henning; D J Pasta; S Fromm; R C Rosen
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

9.  Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

Authors:  Carol M Moinpour; Amy K Darke; Gary W Donaldson; Ian M Thompson; Connie Langley; Donna Pauler Ankerst; Donald L Patrick; John E Ware; Patricia A Ganz; Sally A Shumaker; Scott M Lippman; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2007-06-27       Impact factor: 13.506

10.  Changes in sexual function on mood and quality of life in patients undergoing radiation therapy for prostate cancer.

Authors:  Kristie Howlett; Theresa Koetters; Janet Edrington; Claudia West; Steven Paul; Kathryn Lee; Bradley E Aouizerat; William Wara; Patrick Swift; Christine Miaskowski
Journal:  Oncol Nurs Forum       Date:  2010-01       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.